Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04021810Not ApplicableTerminated

Combination Therapy Associating CPAP and Mandibular Advancement Device in OSA

Role: collaborator

NCT02878629Completed

Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas

Role: lead

NCT03788187Not ApplicableCompleted

Persistant Organics Pollutants in Breast Cancer.

Role: collaborator

NCT02348970Not ApplicableCompleted

Efficacy and Compliance of the Mandibular Advancement Devices ONIRIS® vs. Custom Made Devices

Role: lead

NCT03334019Unknown

Prevalence and Risk Factors for Coxiella Burnetii Seropositivity (Q Fever) Among Adults in Western France

Role: collaborator

NCT02651077Completed

Endometriosis and Brominated Flame Retardant (ENDOTOX Study)

Role: collaborator

All 6 trials loaded